After being bought out last August by London-based investment firm Cinven, Bioclinica has made three senior hires for its medical imaging and biomarkers unit.

Buzz about LabCorp’s secret intention to take over INC Research had just started to quiet down when the life sciences company announced a deal—a settled one—to…

Chinese CRO Pharmaron has bought out U.S. accelerator mass spectrometry specialist Xceleron to boost its radiolabeled sciences offering.

Pfizer might be able to identify potential safety issues of drug candidates in early stages, as it just licensed a human cell line designed to do that from…

Evotec is participating in the €8 million ($8.46 million) Series A of its current partner in developing metabolic disease therapy Eternygen.

Draper has signed a three-year deal with Big Pharma giant Pfizer to help predict clinical outcomes from an early stage through the use of its…

Crown Bioscience will invest $1 million into establishment of a pharmaceutical R&D facility in Louisiana at New Iberia Research Center, one of the country’…

Rumors that PPD’s owners intend to sell the CRO refuse to die, with reports emerging once again that it is on the block for about $5 billion.

Charles River Laboratories has launched CRISPR/Cas9 services through a licensing deal with the Broad Institute, as a dispute over ownership of the technology…

Spanish CRO Kymos has closed a deal to acquire Italy's Pharmaprogress as part of an ongoing expansion in the European market.

Deals